1. Home
  2. TAK vs GRMN Comparison

TAK vs GRMN Comparison

Compare TAK & GRMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TAK
  • GRMN
  • Stock Information
  • Founded
  • TAK 1781
  • GRMN 1990
  • Country
  • TAK Japan
  • GRMN Switzerland
  • Employees
  • TAK N/A
  • GRMN N/A
  • Industry
  • TAK Biotechnology: Pharmaceutical Preparations
  • GRMN Industrial Machinery/Components
  • Sector
  • TAK Health Care
  • GRMN Industrials
  • Exchange
  • TAK Nasdaq
  • GRMN Nasdaq
  • Market Cap
  • TAK 42.5B
  • GRMN 42.0B
  • IPO Year
  • TAK N/A
  • GRMN 2000
  • Fundamental
  • Price
  • TAK $13.32
  • GRMN $209.70
  • Analyst Decision
  • TAK
  • GRMN Hold
  • Analyst Count
  • TAK 0
  • GRMN 6
  • Target Price
  • TAK N/A
  • GRMN $170.50
  • AVG Volume (30 Days)
  • TAK 1.8M
  • GRMN 788.3K
  • Earning Date
  • TAK 01-30-2025
  • GRMN 10-30-2024
  • Dividend Yield
  • TAK 4.74%
  • GRMN 1.43%
  • EPS Growth
  • TAK 49.73
  • GRMN 45.02
  • EPS
  • TAK 1.27
  • GRMN 7.86
  • Revenue
  • TAK $31,732,209,416.00
  • GRMN $5,956,843,000.00
  • Revenue This Year
  • TAK $4.41
  • GRMN $20.08
  • Revenue Next Year
  • TAK $1.09
  • GRMN $8.87
  • P/E Ratio
  • TAK $20.89
  • GRMN $26.83
  • Revenue Growth
  • TAK 9.43
  • GRMN 17.91
  • 52 Week Low
  • TAK $12.58
  • GRMN $119.15
  • 52 Week High
  • TAK $15.08
  • GRMN $222.97
  • Technical
  • Relative Strength Index (RSI)
  • TAK 40.07
  • GRMN 49.87
  • Support Level
  • TAK $13.26
  • GRMN $216.10
  • Resistance Level
  • TAK $13.42
  • GRMN $220.41
  • Average True Range (ATR)
  • TAK 0.14
  • GRMN 3.17
  • MACD
  • TAK -0.02
  • GRMN -1.82
  • Stochastic Oscillator
  • TAK 7.95
  • GRMN 4.78

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

About GRMN Garmin Ltd. (Switzerland)

Garmin produces GPS-enabled hardware and software for five verticals: fitness, outdoors, auto, aviation, and marine. The company relies on licensing mapping data to enable its hardware specialized for often niche activities like scuba diving or sailing, among many others. Garmin operates in 100 countries and sells its products via distributors as well as relationships with original equipment manufacturers.

Share on Social Networks: